RTRecep Temel

Recep Temel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Recep Temel has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Association of Pathological Complete Response with Long-Term Oncological Outcomes After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Retrospective Analysis of 327 Patients

    by Berk Sertoz, Kamil Erozkan, Recep Temel, Murat Sezak, Basak Doganavsargil, Osman Bozbiyik, Cemil Caliskan, Erhan Akgun

    Background and Objectives: While total neoadjuvant therapy (TNT) is increasingly adopted, conventionally fractionated neoadjuvant chemoradiotherapy (CRT) followed by surgery remains the standard approach for many patients with locally advanced rectal cancer (LARC). Tumor regression following neoadjuvant therapy varies, potentially influencing oncologic outcomes. This study aimed to evaluate the association between pathological complete response (pCR) and long-term overall survival (OS) and disease-free survival (DFS) in patients with LARC undergoing neoadjuvant therapy and surgery. Materials and Methods: This retrospective study included patients who received long-course radiotherapy with concurrent capecitabine, followed by curative-intent surgery between January 2006 and January 2017. Patients were stratified according to the presence or absence of pCR. The primary outcomes were 5-year OS and DFS; secondary outcomes included locoregional recurrence and distant metastasis rates. Results: Among 327 patients, 47 (14.4%) achieved pCR. Patients with pCR had significantly lower pretreatment clinical T stage (p = 0.033) and clinical N stage (p = 0.049) and were more frequently classified as clinical stage II (55.3% vs. 40.0%, p = 0.049). Long-term oncological analyses included 322 patients after the exclusion of five early postoperative deaths. Locoregional recurrence (6.4% vs. 9.8%, p = 0.59) and distant metastasis (10.6% vs. 20.0%, p = 0.15) were numerically less frequent in the pCR group but did not differ significantly. Five-year OS was 91.5% in the pCR group and 73.1% in the non-pCR group (log-rank p = 0.027), while 5-year DFS was 85.1% and 61.5%, respectively (log-rank p = 0.008). After adjustment for age, sex, tumor location, pretreatment clinical T and N stage, and the CRT-to-surgery interval, pCR remained associated with improved DFS (adjusted HR 0.542, 95% CI 0.296–0.994, p = 0.048). In contrast, the association between pCR and OS was attenuated and did not reach statistical significance (adjusted HR 0.575, 95% CI 0.305–1.083, p = 0.087). Conclusion: pCR following neoadjuvant therapy in patients with LARC is associated with favorable long-term oncological outcomes. After adjustment for baseline clinical characteristics, pCR remained associated with improved DFS, whereas its association with OS was attenuated and did not reach statistical significance. These findings support the prognostic relevance of pCR while emphasizing the contribution of baseline disease characteristics to long-term survival.

  • Open Access

    Long-term recurrence after inguinal hernia repair in a single-surgeon cohort using predefined mesh per approach

    by Tufan Gümüş, Erkan Güler, Tolga Girgin, Recep Temel, Volkan Sayur, Sinan Ersin

    We aimed to evaluate, within a single-surgeon, predefined, approach-specific mesh protocol, whether the surgical approach (laparoscopic vs. open) is independently associated with long-term recurrence after adjusting for patient-related factors. A total of 314 patients who underwent surgery using both laparoscopic and open techniques between 2013 and 2022 by a single expert general surgeon were analyzed. The patients’ age, gender, hernia side, body mass index (BMI), comorbidities, preoperative American Society of Anesthesiologists scores, type of operation, postoperative complications, and recurrence rates during follow-up were retrospectively reviewed from the Electronic Patient File (EPF) system. Repairs followed a predefined, approach-specific mesh protocol (self-gripping mesh for open repairs; pre-formed polypropylene mesh for laparoscopic repairs). The median follow-up duration was 72 months (IQR 56.5–102; range 26–140 months). Overall recurrence was observed in 24 of 314 patients (7.6%) during follow-up. Crude rates were similar between approaches (7.3% after open [14/192] vs. after laparoscopic 8.2% [10/122], p = 0.769). In multivariable analysis, diabetes mellitus, cardiovascular disease, and prior repair emerged as independent predictors of recurrence. In a standardized setting minimizing surgeon and implant heterogeneity, recurrence was approximately 8% at a median follow-up of about 6 years and was primarily associated with patient-related factors, such as comorbidity and prior repair, rather than surgical approach. Within the context of this cohort, these findings should be interpreted as hypothesis-generating and may reflect recurrence patterns observed under standardized conditions, rather than a definitive lower-bound benchmark. They also highlight the potential relevance of pre- and perioperative risk optimization beyond surgical approach selection alone.

  • Survival outcomes and prognostic factors in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: A single-center retrospective study

    by Özgür Kılınçarslan, Volkan Sayur, Erkan Güler, Recep Temel, Özgün Cevdet Köse, Ozan Verendağ, Taylan Özgür Sezer

    Background: Peritoneal carcinomatosis (PC) represents an advanced stage of intra-abdominal malignancies with poor prognosis. Cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) offers promising outcomes in selected patients. This study evaluated survival and prognostic factors in patients undergoing CRS-HIPEC for malignancy-associated PC. Methods: A retrospective analysis was performed on 116 patients treated with CRS-HIPEC between 2015 and 2023. Data included demographics, tumor origin, peritoneal cancer index (PCI), completeness of cytoreduction (CC) score, complications, and survival outcomes. Kaplan–Meier and Cox regression analyses were used. Results: The mean age was 55.2 years; 61.2% were female. Common primary tumors were colorectal (34.5%), gastric (20.7%), ovarian (17.2%), and appendiceal (16.4%). Mean PCI was 11.9, and complete cytoreduction (CC-0) was achieved in 89.7%. Overall survival was highest in appendiceal (76.9 months) and lowest in gastric cancer (24.7 months). Median disease-free and overall survival were 36 and 43.9 months, respectively. Postoperative complications occurred in 31.8%; mortality was 5.17%. High PCI and incomplete cytoreduction were independently associated with worse survival. Conclusion: CRS-HIPEC provides encouraging survival in selected PC patients, especially with low PCI and complete cytoreduction. Careful patient selection remains key to optimizing outcomes.


  • Open Access

    Perineural and Lymphovascular Invasion in Resected Pancreatic Ductal Adenocarcinoma: A High-Risk Subgroup That Could Benefit from Adjuvant Radiotherapy

    by Tufan Gümüş, Aykut Özkılıç, Recep Temel, Deniz Nart, Funda Yılmaz, Bülent Karabulut, Alper Uğuz

    Background: Perineural invasion (PNI) and lymphovascular invasion (LVI) are adverse prognostic factors in pancreatic ductal adenocarcinoma (PDAC). Their concurrence may warrant intensified adjuvant therapy. This study investigated the prognostic impact of concurrent PNI and LVI and the potential benefit of adjuvant radiotherapy. Methods: A retrospective analysis was conducted in patients who underwent pancreaticoduodenectomy for PDAC (2015–2023). Patients were grouped as PNI only, concurrent PNI and LVI, or neither. Clinicopathological features and survival outcomes were compared. In the concurrent PNI and LVI subgroup, the effect of adjuvant radiotherapy was analyzed according to margin status (R0 vs. R1). Disease-free survival (DFS) and overall survival (OS) were assessed using Kaplan–Meier and Cox models. Results: Eighty-eight patients were included. Recurrence occurred in 83.0%, with locoregional recurrence in 30.1%. Median DFS was 10.5 months and OS was 19.0 months; four patients (4.5%) survived ≥5 years. Concurrent PNI and LVI was observed in 55.7% and independently predicted reduced DFS (HR 3.23; p = 0.002) and OS (HR 2.34; p = 0.02), whereas adjuvant radiotherapy was associated with prolonged DFS (HR 0.48; p = 0.008). Among R0-resected patients with concurrent PNI and LVI, radiotherapy reduced locoregional recurrence (6.3% vs. 46.7%; p = 0.01) and improved median DFS (10.0 vs. 7.0 months; p = 0.04). Conclusions: Patients with concurrent PNI and LVI are a high-risk subgroup of PDAC. Adjuvant radiotherapy after R0 resection may improve DFS and reduce recurrence in these patients.

  • Negatif apendektomi tarih mi oluyor? Tersiyer bir merkezin 10 yıllık sonuçları

    by Yiğit Türk, Recep Temel, Büşra Küçükateş, Volkan Sayur, Tufan Gümüş, Kamil Erözkan, Berk Göktepe

    Amaç: Çalışmamızın amacı, akut apandisit ön tanısıyla opere edilen hastalarda negatif apendektomi oranını belirlemek ve negatif apendektomi ile ilişkili klinik, laboratuvar ve görüntüleme parametrelerini değerlendirmektir. Gereç ve Yöntem: Ege Üniversitesi Tıp Fakültesi Hastanesi Genel Cerrahi Anabilim Dalı’nda, 2014-2024 yılları arasında akut apandisit ön tanısıyla laparoskopik veya açık teknik ile cerrahi girişim uygulanan 18 yaş üstü hastalar retrospektif olarak incelenmiş; postoperatif patoloji sonuçlarına göre akut apandisit (AA) ve negatif appendektomi (NA) olmak üzere iki gruba ayrılmıştır. Bulgular: İkibinüçyüzotuz hastanın %58,2’si (1355) erkek, %41,8’i (975) kadın olup, ortalama yaş 39,78±16,49 yıl olarak belirlenmiştir. Negatif apendektomi oranı %2,1 olarak tespit edilmiştir. NA grubunda kadın cinsiyetin oranı anlamlı derecede yüksek bulunmuştur (p=0,001). Görüntüleme yöntemleri incelendiğinde, yalnızca ultrasonografi (USG) kullanımının negatif apendektomi ile anlamlı düzeyde ilişkili olduğu saptanmıştır (p<0,001). Bilgisayarlı tomografi (BT) kullanımı, negatif apendektomi riskini %98,1 oranında azaltmış (OR: 0,019; p<0,001); BT ve USG birlikte kullanıldığında ise bu oran %98,5’e kadar azalttığı saptanmıştır (OR:0,015; p<0,001). Ayrıca AA grubunda nötrofil(p=0,004), lökosit(p=0,024), hemoglobin(p=0,007) ve hematokrit(p=0,013) düzeyleri anlamlı olarak daha yüksek; trombosit sayısı ise belirgin şekilde düşük bulunmuştur(p=0,002). Nötrofil/lökosit oranı (NLR), AA grubunda NAi grubuna göre anlamlı derecede yüksek olup (p=0,001), çok değişkenli analizlerde de bağımsız bir prediktif faktör olarak kalmıştır (p=0,035). Sonuç: Kadın cinsiyet ve yalnızca USG kullanımı negatif apendektomi riskini anlamlı şekilde artırmaktadır. NLR değeri, negatif apendektomiyi öngörmede bağımsız bir biyobelirteç olarak kullanılabilir niteliktedir. Elde edilen veriler, akut apandisit tanısında klinik değerlendirme, görüntüleme bulguları ve laboratuvar parametrelerinin entegre edilmesinin, gereksiz cerrahi müdahaleleri azaltmada kritik bir rol oynadığını desteklemektedir.

  • Open Access

    Adrenal Hematoma Volume as a Predictor of Morbidity and Mortality in Traumatic Adrenal Injury

    by Yiğit Türk, Aykut Özkılıç, Hüsnügül Karakoç, Recep Temel, Ezgi Güler, Gökhan İçöz, Özer Makay, Murat Özdemir

    Background: Traumatic adrenal injury (TAI) is a rare but significant condition that affects 2.5% of patients with thoracoabdominal trauma. The impact of adrenal hematoma volume on clinical outcomes remains underexplored. This study aimed to evaluate factors associated with morbidity and mortality in patients with TAI, with a particular focus on adrenal hematoma volume as a predictive marker. Methods: Retrospective data from patients with radiologically confirmed TAI between 2013 and 2023 was analyzed. Clinical, demographic, and radiological variables were reviewed. Hematoma volume was calculated from computed tomography (CT) imaging and analyzed using univariate and multivariate models. Receiver operating characteristic (ROC) analysis was employed to evaluate its predictive accuracy. Results: Sixty patients were included in the study. The median hematoma volume was 16.0 cm3, with a predominance of injuries on the right side. The morbidity and mortality rates were 18.3% and 8.3%, respectively. Univariate analysis identified a lower Glasgow Coma Scale (GCS) score, higher Injury Severity Score (ISS), and increased hematoma volume as significant factors. In multivariate analysis, hematoma volume and GCS score remained independent predictors of adverse outcomes. A volume threshold of >23 cm3 was associated with significantly higher morbidity and mortality (AUC = 0.80, 95% CI: 0.68–0.92). Conclusions: This study is the first to demonstrate that the volume of adrenal hematoma is an independent predictor of adverse outcomes in patients with traumatic adrenal injury. Integrating volume into clinical assessment may help identify high-risk patients requiring improved observation and management.

  • Open Access

    Long-Term Efficacy of Single-Incision Laparoscopic Intragastric Resection in Treating Gastrointestinal Stromal Tumors

    by Veysel Umman, Özgür Kılınçarslan, Recep Temel, Yener Bağdat, Sarp Tunalı, Sinan Ersin, Taylan Özgür Sezer, Özgür Fırat

    Background/Aims: Gastrointestinal stromal tumors (GISTs), the most common mesenchymal tumors in the gastrointestinal tract, are increasingly treated with minimally invasive surgeries. Developed techniques include laparoscopic, endoscopic, and hybrid methods for gastric GIST resection. Our study, focusing on single-incision laparoscopic intragastric resection for gastric GISTs, aims to evaluate its safety, efficacy, and long-term outcomes. Materials and Methods: In a retrospective study of GIST surgery involving 14 patients who underwent single-incision laparoscopic intragastric resections, we analyzed and compared their preoperative demographics, American Society of Anesthesiologists (ASA) scores, tumor size, neoadjuvant treatment, operation duration, hospital stay, mitotic and Ki-67 indexes, and histological features with those of patients who underwent open and laparoscopic wedge resections, to assess the impact on both survival and disease-free survival. Results: Average operation time was 93.07 minutes (range 81-120 minutes). Average blood loss: 67 +- 20 mL (range 40-110 mL). Postoperative hospital stay averaged 6.79 days (range 4-16 days). Strong correlations were observed between preoperative and pathological tumor sizes (P = .001, P < .001). Survival analysis indicated a significant association with ASA scores (P = .031), but not with mitotic index, Ki-67, or tumor size. Average survival was 80.57 months, with no recurrence or metastasis during follow-up. Conclusion: Based on our experience, the single-incision laparoscopic intragastric resection method emerges as a highly efficient, timesaving, and gentle oncological procedure, providing a safe and minimally invasive alternative resulting in shorter hospital stays and excellent long-term outcomes with minimal recurrence. For more definitive conclusions, larger, multicenter, and prospective studies are recommended. Cite this article as: Umman V, KılınÇarslan ö, Temel R, et al. Long-term efficacy of single-incision laparoscopic intragastric resection in treating gastrointestinal stromal tumors. Turk J Gastroenterol. 2024;35(3):193-203.


  • Open Access

    Knowledge of energy-based devices among surgical residents: a cross-sectional study

    by Can Uc, Yigit Turk, Pınar Uc, Recep Temel, Murat Ozdemır, Ozer Makay

    Uc C, et al. Ann Surg Treat Res. 2024 Nov;107(5):300-304. https://doi.org/10.4174/astr.2024.107.5.300


  • Open Access

    Metabolic and surgical factors affecting postoperative quality of life in patients with total pancreatectomy with or without splenectomy: Single center results

    by Veysel Umman, Tufan Gümüş, Ebubekir Korucuk, Recep Temel, Fırat Başçı, Alper Uguz, Murat Zeytunlu

    Objective: Pancreatic resection may be required in the treatment of patients with pathologies of the pancreas. Total pancreatectomy is a major surgical procedure with serious risk of mortality and morbidity, and patient selection is important for prognosis. The endocrine and exocrine pancreatic insufficiency that develops in patients after total pancreatectomy can lead to a serious decrease in the quality of life of the patients due to pain, diarrhea, vomiting etc. Our aim was to evaluate the effect of total pancreatectomy with spleen preservation as well as splenectomy on the quality of life of the patients. Material and Methods: In our study, we retrospectively analyzed the data of patients diagnosed with pancreatic cancer, intrapapillary mucinous neoplasia, pancreatic neuroendocrine tumors, and chronic pancreatitis undergoing from partial to total pancreatic resections in our clinic between 12/2017 and 12/2022. Quality of life was compared using the EORTC QLQ-C30 scale. Results: A total of 47 total pancreatectomy patients, 30 (63.8%) males and 17 (36.2%) females, were included in the study. Mean age of the patients was 61.38 (39-83) years. Five (35.7%) patients underwent perioperative total pancreatectomy because of high risk of pancreatic fistula development due to hard parenchyma and narrow pancreatic duct. Patients had a perioperative blood loss of 500 mL or more, and there was a statistically significant increase in perioperative blood loss compared to patients without vascular resection (p< 0.001). Forty (85.1%) patients used enzyme preparations to replace pancreatic enzymes. Conclusion: After total pancreatectomy, quality of life of the patients is reduced both by surgical factors and by metabolic factors due to endocrine and exocrine insufficiency in the postoperative period.


  • Open Access

    A new method for predicting alcohol relapse in patients undergoing liver transplantation for alcohol-related liver failure: Barratt scale

    by Veysel Umman, Ebubekir Korucuk, Recep Temel, Ozen Onen Sertoz, Fulya Gunsar, Alper Uguz, Murat Zeytunlu, Sukru Emre

    Background and Aim: Alcohol-induced liver disease has become one of the major causes of chronic liver disease worldwide with the increasing use of alcohol in society. The most important step in treatment is cessation of alcohol consumption. In patients with advanced liver disease, the most effective treat-ment is liver transplantation. Careful evaluation of patients with alcoholic liver disease before transplantation can help identify those at high risk of relapsing. Materials and Methods: Of a total of 42 patients who underwent liver trans-plantation for alcohol-related liver failure in our hospital between 2011 and 2022, 26 surviving patients were included in the study. Patient data were analyzed ret-rospectively. Demographic data, MELD score, history of alcohol consumption, alcohol treatment, post-transplant prognosis and survival were analyzed. The Barratt Impulsivity Scale-11 Short Form (BIS-11 SF) was applied to the surviv-ing patients for impulsivity analysis to predict the possibility of relapse. Results: Of the 26 patients who were included in the study, all were male. The mean age at transplantation was 53 (31–71) years. Mean MELD score was 22.31 (9–36). 12 patients (46.2%) received living donor liver transplan-tation and 14 patients (53.8%) received cadaveric liver transplantation. 25 patients (96.2%) had no post-transplant dependence, while 1 patient (3.8%) had post-transplant dependence. 5 patients (19.2%) continued to consume alcohol after transplantation. Conclusion: In our study, we observed that patients with high motor impul-sivity tendency according to BSI-11 SF had alcohol relapse. We believe that revising this scale with more detailed questions for alcohol-dependent liver patients and applying it to patients before transplantation will be effective in better selection for transplantation and guiding patients to appropriate therapy and thus preventing relapse after transplantation.